ページ5 - トルコで最高の診断科医師 - トップ238名の医師

Dr. Ibrahim Cansaran Tanıdır is a pediatric cardiologist at Memorial Ataşehir Hospital. He co-founded the Pediatric Cardiology Department at Başakşehir Çam & Sakura City Hospital. He led its cardiac catheterization laboratories. He has been a professor of pediatric cardiology since 2022.

He has over 100 international and over 50 national publications. His work has more than 1,200 citations, with an h-index of 16. He has delivered over 100 international and over 700 national presentations. He has received six national and one international award. He ranked second in Turkey in the 2017 National Pediatric Cardiology Board Exam. He served as AEPC National Representative (2011–2014) and as Vice President of the Interventional Cardiology Working Group (2019–2024). His training includes Arkansas Children’s (PICU), Fuwai Heart Center (angiography), and LVAD training in 2023. Since 2018, he has performed more than 250 therapeutic angiography procedures in Kosovo, Libya, Mali, Uganda, and Kenya.

Dr. Ulvi Gulmammadov is a Check-Up Physician at Memorial Göztepe Hospital (2025–present). He graduated from the Istanbul University Faculty of Medicine (2001–2008). He is a member of the Turkish Medical Association.

He works in preventive and hospital medicine. He spent 6 years in check-up and occupational practice at Acıbadem Atakent Hospital (2014–2020). He served as Medical Director at Focusmed Health Tourism for 5 years (2020–2025). He worked as a Ward Physician at Taksim German Hospital for 2 years (2012–2014). He also worked 4 years in Emergency Medicine at Emsey Medical Center and Bezmialem Vakıf Gureba Hospital (2008–2012). He has professional training in Occupational Medicine.

Dr. Nesrin Tutas Gunaydin is an ophthalmology specialist at Memorial Goztepe Hospital since 2025. She previously worked at Memorial Bahcelievler Hospital from 2023 to 2025. She served as Chief Assistant at Dr. Lutfi Kirdar Kartal City Hospital from 2016 to 2023. Before that, she held the same role at Dr. Sadi Konuk Bakirkoy Training and Research Hospital in 2015–2016. She completed her ophthalmology residency at University of Health Sciences–Dr. Lutfi Kirdar in 2005–2010. She earned her MD from Istanbul University in 1998–2004.

Accreditations include a Corneal Transplantation Certificate (2011) and an Eye Bank Medical Director Certificate (2021). She has 35 journal articles and 55 national congress papers. She wrote three book chapters and contributed to two international chapters. She also translated Kanski, Vaughan & Asbury: General Ophthalmology. She is a member of the Turkish Ophthalmological Society and ESCRS. She attended TOD National Congresses from 2005 to 2022.

Dr. Derya Can has been an Assistant Professor of Dermatology at Medipol Health Group since 2021. She diagnoses and treats diseases of the skin, hair, nails, and mucosa. Her areas of expertise include eczema, atopic dermatitis, acne, psoriasis, sexually transmitted infections, warts, herpes, shingles, and fungal infections.

Dr. Can manages both benign and malignant skin tumors. She also treats hair and nail disorders, vitiligo, and other common skin conditions. She performs advanced procedures such as hair transplantation and PRP therapy for hair loss.

Education:

• Degree: Faculty of Medicine, Trakya University, 2009
• Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
• Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
• Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
• Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
• Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

Roles in Projects:

Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

Dr. Mustafa Serkan Durdu is a cardiovascular surgeon at Memorial Göztepe Hospital. He previously worked at Memorial Ankara Hospital and Ankara University. He focuses on minimally invasive heart and valve surgery. His work includes right anterior minithoracotomy and combined procedures.

He has published peer-reviewed studies on sutureless aortic valve replacement. His work also covers multiple valve implantation via right anterior thoracotomy, valve surgery with right coronary artery bypass, and molecular markers of chronic atrial fibrillation. His papers have appeared in The Journal of Thoracic and Cardiovascular Surgery, Heart, Lung and Circulation, and The Thoracic and Cardiovascular Surgeon.

He earned his MD from Erciyes University. He completed cardiovascular surgery training at Ankara University and additional training in biotechnology and genetics. He is a member of EACTS, ISMICS, MIRC, and Turkish societies for cardiovascular surgery, vascular surgery, and hematology.

Dr. Rahsan Adviye is a Neurology Specialist at Memorial Göztepe Hospital (2025–present). She has over 20 years of specialist practice in Istanbul. She previously worked at Fatih Medical Park (2004–2008) and Hisar Hospital (2009–2010). From 2010 to 2025, she served as a Neurology Specialist and instructor at the University of Health Sciences, Kartal Dr. Lütfi Kirdar City Hospital. This post included 15 years of academic teaching.

She completed her Neurology residency at Istanbul University Cerrahpaşa Faculty of Medicine (1999–2004). She earned her M.D. there in the English-language program (1991–1998). She is a member of the Turkish Neurology Society, the Istanbul Medical Chamber, and the EEG-EMG Clinical Neurophysiology Society. She attended the Master’s Program in Clinical Neurophysiology at Istanbul University. She has also taken part in many national and international scientific meetings.

Dr. Nurullah Bulut is an ophthalmology specialist at Memorial Göztepe (2025–) and Memorial Bahçelievler (2023–). He previously worked at the University of Health Sciences Kartal Dr. Lütfi Kırdar as a specialist (2013–2022) and as an associate professor (2022–2023). He received the title of associate professor (Doçent) in 2022.

He has 26 peer-reviewed articles, 29 conference papers, one book chapter, and a patent application for an intraocular lens design. He is a member of EURETINA YOURS, the Turkish Medical Association, and the Turkish Ophthalmological Society.

Training: ESCRS PRK/LASEK/Epi-LASIK/LASIK course (2011); ocular electrophysiology, Germany (2011); vitreoretinal surgery observer program, University of Chicago (2014). Education: MD, Atatürk University (2008). Ophthalmology specialization, Kartal Dr. Lütfi Kırdar (2009–2013).

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Dr. Mustafa Serkan Durdu is a cardiovascular surgeon at Memorial Ankara Hospital (2022–present). He previously worked at the Ankara University Department of Cardiovascular Surgery. His focus is minimally invasive valve surgery. He performs right anterior minithoracotomy, sutureless aortic valve replacement, multiple valve implantation, and combined valve surgery with right coronary artery bypass.

He has peer-reviewed publications in J Thorac Cardiovasc Surg, Thorac Cardiovasc Surg, Heart Lung Circ, Semin Thorac Cardiovasc Surg, and Cardiovasc Ther. His work includes studies on molecular signatures of chronic atrial fibrillation in primary mitral regurgitation. Qualifications: Cardiovascular Surgery specialization (Ankara University) and MD (Erciyes University). Memberships: EACTS, ISMICS, MIRC, Turkish Society of Cardiovascular Surgery, National Society of Vascular Surgery, and Turkish Society of Hematology.

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

EDUCATION:

2009

Ankara Etlik Maternity Hospital and Gynecology Education and Research Hospital, Gynecology and Obstetrics

2003

Ankara University, Faculty of Medicine

EXPERIENCE:

2019 - to present

Medipol University Pendik Hospital

2009 - 2019

Yakacık Maternity and Child Diseases Hospital

PUBLICATIONS:

Articles Published in Journals Indexed in SCI, SSCI and AHCI

Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial

YİĞİT E., ÜNSAL S.

Climacteric , 2024 (SCI-Expanded)

Dr. Kazibe Demir is an Obstetrics and Gynecology Specialist at Memorial Göztepe Hospital (2025–). She previously worked at Kadıköy Medicana Hospital (2022–2025) and Dr. Lütfi Kırdar Kartal Training and Research Hospital (2018–2022). She focuses on urogynecology.

Education: MD, Ankara University (2010). Obstetrics and Gynecology residency, Ankara University Faculty of Medicine (2016). PhD program in Urogynecology, Ankara University – University of Health Sciences (2020–2025).

Professional memberships: Turkish Urogynecology and Pelvic Rehabilitation Society; International Urogynecological Association (IUGA). Continuing education: IUGA 2025 (Barcelona). EUGA 2025 (Varese). Turkish Urogynecology and Pelvic Rehabilitation Society Meeting 2024 (Istanbul).

Dr. Ozgur Kilickesmez is an interventional neuroradiology and interventional radiology specialist at Memorial Goztepe Hospital in Istanbul (2025–present). He previously worked at Medicana Atakoy and Zincirlikuyu (2024–2025). He also served at Basaksehir Cam ve Sakura City Hospital (2020–2024), Istanbul Training and Research Hospital (2012–2020), and Guy’s and St Thomas’ Hospital in London (2011–2012).

He is a Professor at the University of Health Sciences (2020). He was an Associate Professor at Yeditepe University Hospital (2010). He completed training in interventional oncology at King’s College University (2011) and in interventional radiology at Cerrahpasa (2010). He provides international training in minimally invasive tumor therapy, non-surgical thyroid interventions, new-generation embolization, and stent-based brain aneurysm treatment. He is a member of RSNA, ESR, CIRSE, and ESNR. He also belongs to Turkish radiology, neuroradiology, interventional radiology, and oncology societies.

Diseases

• Lung Cancer
• Skin Cancers
• Gastrointestinal Cancers
• Genitourinary Cancers
• Gynecological Cancers
• Colon Cancer
• Breast Cancer
• Rare Cancers

Treatment Methods

• Individual Treatments (Comprehensive Genomic Profiling)
• Targeted Therapies
• Immunotherapy
• Cancer Vaccines
• Chemotherapy
• Clinical Research/Experimental Medical Research

Experience

• 2017- 2024: Katip Çelebi University Faculty of Medicine Atatürk Education and Research Hospital Medical Oncology Clinic Associate Professor / Lecturer
• 2022 December – 2023 March: Academic visitor Moffitt Cancer Center Cutaenous Oncology Clinic Tampa, Florida USA
• 2013- 2017: Katip Çelebi University Faculty of Medicine Atatürk Training and Research Hospital – Medical Oncology Clinic Specialist Physician
• 2012-2013: Izmir Education and Research Hospital, Medical Oncology Specialist Physician
• 2012-2012: Mersin State Hospital, Medical Oncology Specialist Physician
• 2010-2012: Dokuz Eylül University Faculty of Medicine, Department of Medical Oncology, Sub-branch Research Assistant
• June-August 2008, December 2008 – February 2009: Memorial Sloan Kettering Cancer Center Observership programme
• 2007-2009: Kartal Education and Research Hospital, Medical Oncology Sub-branch Research Assistant
• 2006-2007: Siirt State Hospital, Internal Medicine, Specialist Physician
• 2005-2006: Çukurova University Faculty of Medicine, Medical Oncology Sub-branch Research Assistant
• 2004-2005: SSK Siirt Hospital, Internal Medicine Specialist Physician
• 2003-2004: SSK Mardin Hospital, Internal Medicine Specialist Physician
• 1998-2003: SSK Izmir Training and Research Hospital, 3rd Internal Medicine Clinic, Research Assistant
• 1998-1998: SSK Izmir Training and Research Hospital Infectious Diseases Research Assistant
• 1997-1998: Izmir Ataturk Training and Research Hospital, Anesthesiology and Reanimation Clinic, Research Assistant
• 1995-1997: Şırnak Cizre Central Health Center
• 1994-1995: Şırnak İdil Oyalı Village Health Center

Professional Memberships

• Turkish Society of Medical Oncology 2008 
• (2018-2021 Term Board Member)
• Izmir Oncology Group, Board Member (2014 -…)
• Geriatric Oncology Association, Board Member (2015-…)
• Mediterranean Oncology Association Board Member (2020 -…)
• Turkish Biochemistry Association, Member, 2016
• European Society of Medical Oncology, Member, 2012
• American Society of Clinical Oncology, Member, 2008

Dr. Bulen Can is an endocrinology specialist at Memorial Göztepe Hospital (2025–present). He previously worked at Acıbadem Ataşehir (2024–2025). From 2017 to 2024, he was a faculty member in the Division of Endocrinology at Istanbul Medeniyet University. He also practiced at Ankara Numune, Kastamonu Dr. M. İslamoğlu, and Ümraniye Training and Research Hospitals. He has been an endocrinology specialist since 2013.

He completed subspecialty training in Endocrinology and Metabolic Diseases at Istanbul University, Istanbul Faculty of Medicine (2009–2013). Before that, he finished his Internal Medicine residency at Bezm‑i Âlem Vakıf Gureba (2003–2009). He received his M.D. from the Istanbul Faculty of Medicine. He is a member of TEMD, TİHUD, TTB, and the Istanbul Medical Chamber. He attended the 46th TEMD Congress (2025), Aydın Endocrine Days (2022), and Clinical Research Training (2017).

Dr. Sumeyre Seda Ertekin is a general surgeon and surgical oncologist at Memorial Göztepe Hospital (2025–present). She previously worked at Academic Hospital (1999–2025), Marmara University Hospital (1991–2010), Gülhane Military Medical Academy Haydarpaşa (1997–1998), and Haukeland University Hospital in Bergen, Norway (2000–2008).

She holds UEMS European Board of Surgery certification in General Surgery (2012) and a subspecialty in Breast Surgery (2012). She completed Ministry of Health subspecialty training in Surgical Oncology (2012). She finished her General Surgery residency at Marmara University (1991–1996).

Memberships and roles: Founding Member, Breast Surgery Association. Country Coordinator, OPBS. Member, EORTC‑BCG, BRESO, IBUS, SENATURK, and the Istanbul Breast Diseases Society. Member, Global Technical Oversight Group (THET–ABS). Honorary Member of the Bulgarian Surgical Society, the Romanian Society of Breast Surgery and Oncology, and ABSI (India).

Dr. Hidayet Demir is a Cardiovascular Surgery Specialist at Memorial Göztepe Hospital (2025–). He previously served as an Assistant Professor at Okan University Hospital (2021–2025). He was also a specialist at Ağrı I. Ç. University Training and Research Hospital (2019–2021). Earlier, he worked at City Health Group as Medical Director and ECMO Specialist (2015–2018). He later served as CEO (2018–2025).

Education: MD, Istanbul University Cerrahpaşa (2007–2013). Cardiovascular Surgery residency, SBÜ Kartal Koşuyolu (2013–2019). Beating‑Heart Coronary Bypass observer, Royal Brompton & Harefield Hospital (2018).

Memberships: TKDCD, UVECD, Turkish Medical Association, ESVS, EACTS. Courses: MIRC 2017 (minimally invasive/robotic). UVECD & EVC 2017 Venous Workshop. European Vascular Course 2017: Open Abdominal Aortic Aneurysm Treatment. TKDCD advanced aortic surgery. ESVS aortic arch techniques.

Dr. Vafa Guliyeva is a pediatric rheumatologist at Memorial Göztepe Hospital in Istanbul. She previously worked at Memorial Şişli and LIV Bona Dea. Before that, she was a pediatrics specialist at Florence Nightingale Hospital.

Training: Pediatric rheumatology subspecialty at Istanbul University and Istanbul Cerrahpaşa University. Pediatrics residency at Istanbul Medeniyet University.

Achievements: Author of 20 international and 3 national peer-reviewed articles. Presented 3 international and 20 national conference papers. Contributed to 4 book chapters. Principal investigator of a BAP scientific project.

Memberships: Turkish Medical Association (TTB). Pediatric Rheumatology Association. Paediatric Rheumatology European Society (PReS).